Texas abortion drug ruling could create 'slippery slope' for FDA approvals, drug research and patients, experts say
Vaccines, including the COVID-19 shots, antidepressants and psychotropic medicines, could be at risk, some said.
Stay updated with breaking news from Goodwin Life Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Vaccines, including the COVID-19 shots, antidepressants and psychotropic medicines, could be at risk, some said.
The U.S. FDA approved mifepristone, part of a two-drug regimen that accounts for more than half of U.S. abortions, over 20 years ago.
By Ahmed Aboulenein WASHINGTON (Reuters) - A federal judge's decision last week to suspend the U.S. Food and Drug Administration's (FDA) approval of a...
WASHINGTON (Reuters) - A federal judge's decision last week to suspend the U.S. Food and Drug Administration's (FDA) approval of abortion pill mifepristone could severely weaken the agency if allowed to stand, health policy and legal experts said. | 06:02am
A federal judge's decision last week to suspend the U.S. Food and Drug Administration's (FDA) approval of abortion pill mifepristone could severely weaken the agency if allowed to stand, health policy and legal experts said.